Masimo Corporation (0JZ2.L)
USD 151.85
(-0.79%)
USD 151.85
(-0.79%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 81.5 Million USD | -43.21% |
| 2022 | 143.5 Million USD | -37.5% |
| 2021 | 229.6 Million USD | -4.45% |
| 2020 | 240.3 Million USD | 22.47% |
| 2019 | 196.21 Million USD | 1.38% |
| 2018 | 193.54 Million USD | 47.05% |
| 2017 | 131.61 Million USD | -56.23% |
| 2016 | 300.66 Million USD | 260.94% |
| 2015 | 83.3 Million USD | 14.87% |
| 2014 | 72.51 Million USD | 24.22% |
| 2013 | 58.38 Million USD | -6.25% |
| 2012 | 62.27 Million USD | -2.24% |
| 2011 | 63.7 Million USD | -13.37% |
| 2010 | 73.53 Million USD | 38.14% |
| 2009 | 53.22 Million USD | 66.72% |
| 2008 | 31.92 Million USD | -24.44% |
| 2007 | 42.25 Million USD | -76.76% |
| 2006 | 181.82 Million USD | 444.7% |
| 2005 | 33.38 Million USD | 968.62% |
| 2004 | -3.84 Million USD | 44.26% |
| 2003 | -6.89 Million USD | -3687.91% |
| 2002 | -182 Thousand USD | 0.0% |
| 1999 | -13.5 Million USD | -62.65% |
| 1998 | -8.3 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 9.8 Million USD | -38.75% |
| 2024 Q1 | 18.9 Million USD | -44.25% |
| 2024 Q2 | 16 Million USD | -15.34% |
| 2023 Q4 | 33.9 Million USD | 219.81% |
| 2023 Q3 | 10.6 Million USD | -32.48% |
| 2023 Q1 | 21.3 Million USD | -47.92% |
| 2023 Q2 | 15.7 Million USD | -26.29% |
| 2023 FY | 81.5 Million USD | -43.21% |
| 2022 Q4 | 40.9 Million USD | 7.92% |
| 2022 Q1 | 46.6 Million USD | -31.73% |
| 2022 Q2 | 18.1 Million USD | -61.16% |
| 2022 Q3 | 37.9 Million USD | 109.39% |
| 2022 FY | 143.5 Million USD | -37.5% |
| 2021 Q2 | 50.2 Million USD | -5.96% |
| 2021 Q1 | 53.38 Million USD | -24.46% |
| 2021 FY | 229.6 Million USD | -4.45% |
| 2021 Q3 | 57.8 Million USD | 15.14% |
| 2021 Q4 | 68.25 Million USD | 18.09% |
| 2020 FY | 240.3 Million USD | 22.47% |
| 2020 Q4 | 70.66 Million USD | 43.04% |
| 2020 Q3 | 49.4 Million USD | -11.42% |
| 2020 Q2 | 55.77 Million USD | -13.47% |
| 2020 Q1 | 64.45 Million USD | 21.8% |
| 2019 Q3 | 49.08 Million USD | 9.35% |
| 2019 FY | 196.21 Million USD | 1.38% |
| 2019 Q1 | 49.32 Million USD | 5.09% |
| 2019 Q2 | 44.88 Million USD | -8.99% |
| 2019 Q4 | 52.92 Million USD | 7.82% |
| 2018 Q3 | 57.12 Million USD | 30.27% |
| 2018 FY | 193.54 Million USD | 47.05% |
| 2018 Q1 | 45.63 Million USD | 12299.46% |
| 2018 Q2 | 43.85 Million USD | -3.89% |
| 2018 Q4 | 46.93 Million USD | -17.84% |
| 2017 Q2 | 45.13 Million USD | -12.41% |
| 2017 Q4 | 368 Thousand USD | -98.97% |
| 2017 Q1 | 51.53 Million USD | -76.06% |
| 2017 FY | 131.61 Million USD | -56.23% |
| 2017 Q3 | 35.85 Million USD | -20.57% |
| 2016 FY | 300.66 Million USD | 260.94% |
| 2016 Q3 | 27.77 Million USD | -7.49% |
| 2016 Q1 | 27.57 Million USD | 14.42% |
| 2016 Q2 | 30.02 Million USD | 8.87% |
| 2016 Q4 | 215.29 Million USD | 675.19% |
| 2015 FY | 83.3 Million USD | 14.87% |
| 2015 Q4 | 24.1 Million USD | 24.71% |
| 2015 Q3 | 19.32 Million USD | -0.13% |
| 2015 Q2 | 19.35 Million USD | -5.71% |
| 2015 Q1 | 20.52 Million USD | -3.29% |
| 2014 Q3 | 14.86 Million USD | 7.69% |
| 2014 Q1 | 22.63 Million USD | 143.02% |
| 2014 Q4 | 21.22 Million USD | 42.78% |
| 2014 FY | 72.51 Million USD | 24.22% |
| 2014 Q2 | 13.8 Million USD | -39.02% |
| 2013 Q4 | 9.31 Million USD | -40.31% |
| 2013 Q3 | 15.6 Million USD | -8.43% |
| 2013 Q2 | 17.03 Million USD | 3.71% |
| 2013 FY | 58.38 Million USD | -6.25% |
| 2013 Q1 | 16.42 Million USD | 9.47% |
| 2012 Q3 | 13.79 Million USD | -22.05% |
| 2012 FY | 62.27 Million USD | -2.24% |
| 2012 Q4 | 15 Million USD | 8.79% |
| 2012 Q1 | 15.77 Million USD | 14.14% |
| 2012 Q2 | 17.69 Million USD | 12.19% |
| 2011 Q1 | 18.01 Million USD | 11.78% |
| 2011 Q3 | 14.82 Million USD | -12.97% |
| 2011 Q4 | 13.82 Million USD | -6.8% |
| 2011 FY | 63.7 Million USD | -13.37% |
| 2011 Q2 | 17.03 Million USD | -5.41% |
| 2010 Q4 | 16.11 Million USD | -1.86% |
| 2010 FY | 73.53 Million USD | 38.14% |
| 2010 Q1 | 26.71 Million USD | 89.97% |
| 2010 Q3 | 16.41 Million USD | 14.92% |
| 2010 Q2 | 14.28 Million USD | -46.51% |
| 2009 Q1 | 13.02 Million USD | 2556.79% |
| 2009 Q4 | 14.06 Million USD | 7.7% |
| 2009 Q3 | 13.05 Million USD | -0.28% |
| 2009 FY | 53.22 Million USD | 66.72% |
| 2009 Q2 | 13.09 Million USD | 0.55% |
| 2008 Q1 | 8.79 Million USD | -21.8% |
| 2008 Q4 | -530 Thousand USD | -104.06% |
| 2008 Q3 | 13.06 Million USD | 23.24% |
| 2008 Q2 | 10.6 Million USD | 20.59% |
| 2008 FY | 31.92 Million USD | -24.44% |
| 2007 Q3 | 10.55 Million USD | -0.06% |
| 2007 Q1 | 9.09 Million USD | -26.49% |
| 2007 Q2 | 10.55 Million USD | 16.04% |
| 2007 FY | 42.25 Million USD | -76.76% |
| 2007 Q4 | 11.24 Million USD | 6.56% |
| 2006 FY | 181.82 Million USD | 444.7% |
| 2006 Q2 | 12.37 Million USD | -91.45% |
| 2006 Q3 | 12.37 Million USD | 0.0% |
| 2006 Q4 | 12.37 Million USD | 0.0% |
| 2006 Q1 | 144.69 Million USD | 1633.94% |
| 2005 Q1 | 8.34 Million USD | 0.0% |
| 2005 FY | 33.38 Million USD | 968.62% |
| 2005 Q2 | 8.34 Million USD | 0.0% |
| 2005 Q3 | 8.34 Million USD | 0.0% |
| 2005 Q4 | 8.34 Million USD | 0.0% |
| 2004 FY | -3.84 Million USD | 44.26% |
| 2003 FY | -6.89 Million USD | -3687.91% |
| 2002 FY | -182 Thousand USD | 0.0% |
| 1999 Q3 | -2.6 Million USD | 0.0% |
| 1999 FY | -13.5 Million USD | -62.65% |
| 1999 Q4 | -4.5 Million USD | -73.08% |
| 1998 FY | -8.3 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 159.539% |
| Accuray Incorporated | -15.54 Million USD | 624.284% |
| Align Technology, Inc. | 445.05 Million USD | 81.688% |
| Elevance Health Inc. | 5.98 Billion USD | 98.639% |
| AxoGen, Inc. | -21.71 Million USD | 475.299% |
| Boston Scientific Corporation | 1.59 Billion USD | 94.884% |
| CVS Health Corporation | 8.34 Billion USD | 99.023% |
| Cardinal Health, Inc. | 852 Million USD | 90.434% |
| Centene Corporation | 2.7 Billion USD | 96.984% |
| DaVita Inc. | 691.53 Million USD | 88.215% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 98.445% |
| Hologic, Inc. | 789.5 Million USD | 89.677% |
| Humana Inc. | 2.48 Billion USD | 96.726% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 90.356% |
| Laboratory Corporation of America Holdings | 418 Million USD | 80.502% |
| McKesson Corporation | 3 Billion USD | 97.285% |
| Patterson Companies, Inc. | 185.93 Million USD | 56.167% |
| Quest Diagnostics Incorporated | 854 Million USD | 90.457% |
| ResMed Inc. | 1.02 Billion USD | 92.017% |
| Henry Schein, Inc. | 416 Million USD | 80.409% |
| Teladoc Health, Inc. | -220.36 Million USD | 136.984% |
| Universal Health Services, Inc. | 717.79 Million USD | 88.646% |
| Veeva Systems Inc. | 525.7 Million USD | 84.497% |
| Baxter International Inc. | 2.65 Billion USD | 96.931% |
| Becton, Dickinson and Company | 1.48 Billion USD | 94.508% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 95.467% |
| Danaher Corporation | 4.2 Billion USD | 98.06% |
| Stryker Corporation | 3.16 Billion USD | 97.425% |
| Medtronic plc | 3.67 Billion USD | 97.783% |